Skip to content
AnalystLens

CME GROUP INC. 8-K Report, Financial Results (Jul 26, 2023)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed July 26, 2023
Period End
July 26, 2023
Security
CME
In the record · 2016–202610-K1110-Q328-K119

CME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’17Nov ’17
  2. Leadership change8-K · Feb ’20Feb ’20
  3. Material agreement8-K · Apr ’22Apr ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed July 26, 2023. Cited figures are marked; the original filing is the authoritative source.

CME Group Inc. filed an 8-K report on July 26, 2023, primarily announcing its financial results for the quarter ended June 30, 2023.

The report incorporates by reference a press release (Exhibit 99.1) that details these results. Investors should note that while GAAP results are provided, the company also presents non-GAAP measures for net income and earnings per share. Management believes these non-GAAP figures offer valuable supplemental information for assessing financial and business trends and comparability with prior periods, though they should be considered alongside, not as a substitute for, GAAP figures.

A reconciliation of these non-GAAP measures to their GAAP equivalents is included in the press release as required by Regulation G. While the specific financial figures are not detailed within the 8-K text itself, the filing signals the release of the company's quarterly performance. Investors are encouraged to review the attached press release for detailed financial performance, including key metrics, revenue drivers, and profitability for the second quarter of 2023.

Key Highlights

  1. CME Group Inc. has announced its financial results for the quarter ended June 30, 2023, via an 8-K filing.
  2. The press release containing the detailed financial results is attached as Exhibit 99.1.
  3. The company is providing both GAAP and non-GAAP financial measures (net income and earnings per share).
  4. Management views non-GAAP measures as important for supplemental analysis of financial trends and comparability.
  5. Non-GAAP figures should be considered in conjunction with, not as a replacement for, GAAP results.
  6. A reconciliation between non-GAAP and GAAP financial measures is provided in the press release, in compliance with Regulation G.

Frequently Asked Questions

  1. What is the main purpose of this 8-K filing?

    The main purpose of this 8-K filing is to announce and provide access to CME Group Inc.'s financial results for the quarter ended June 30, 2023, through an incorporated press release.

  2. What are non-GAAP financial measures and why does CME Group present them?

    Non-GAAP financial measures are financial metrics that are not calculated in accordance with Generally Accepted Accounting Principles (GAAP). CME Group presents non-GAAP net income and earnings per share because management believes they provide important supplemental information to investors and management about financial and business trends and improve comparability with the company's prior financial reports.

  3. Where can I find the detailed financial results?

    The detailed financial results, including both GAAP and non-GAAP figures and their reconciliation, are provided in the press release attached as Exhibit 99.1 to this 8-K filing.

  4. Are the non-GAAP financial measures as important as the GAAP measures?

    While management finds non-GAAP measures useful for supplemental analysis and comparability, they should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.